# Dose-Finding Study of NBX-100 in Healthy Adult Participants

> **NCT07399899** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Neurala Biosciences** · enrollment: 8 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** NBX-100

## Key facts

- **NCT ID:** NCT07399899
- **Lead sponsor:** Neurala Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-31
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-05-30
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07399899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07399899, "Dose-Finding Study of NBX-100 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07399899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*